Hypercalcemia of Malignancy

Hypercalcemia of malignancy (HCM) is a common concern in patients being treated for cancer, affecting over a quarter of this population. There are multiple causes of HCM, including humoral HCM, osteolytic HCM, ectopic hyperparathyroidism, and vitamin D–secreting lymphomas. Common signs and symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldenzer, Kaitlin L., Sarno, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505545/
https://www.ncbi.nlm.nih.gov/pubmed/31086686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505545/
https://www.ncbi.nlm.nih.gov/pubmed/31086686

Ejemplares similares